Jeffrey Greenwald, MD, a hospitalist at Massacusetts General Hospital with 15 years of experience in hospital medicine, discusses his view of the spectrum of endocrine disorders and how hospitalists should approach the question of when to call in an endocrine specialist.
Related Articles
Parathyroidectomy Does Not Reduce Mortality or Morbidity in Mild Primary Hyperparathyroidism
April 4, 2015
Dr. Morvant Clinical question: Does parathyroidectomy improve mortality or morbidity in mild primary hyperparathyroidism? Background: It is known that in patients with severe hypercalcemia or...
![1]()
SGLT2 inhibitor use tied to fewer atrial arrhythmias
April 4, 2015
A prospective study of nearly 14,000 patients who received an implantable cardiac device suggests that SGLT2-inhibitor treatment cuts atrial arrhythmias.
Advanced CKD doesn’t derail empagliflozin in EMPEROR-preserved
April 4, 2015
Study shows empagliflozin led to a consistent, significant relative risk reduction compared with placebo in the primary endpoint.
![1]()
Empagliflozin a winner in challenging arena of stabilized acute HF
April 4, 2015
Early in-hospital initiation of SGLT2 inhibitors “should be considered the new standard of care” in most patients with heart failure regardless of their ejection fraction, says an expert observer.
